A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
Clinical trial NCT05327530 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05327530
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-17
- Primary completion
- 2025-06-20
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.